Artificial heart maker Carmat suspends implants due to quality issue
Carmat on December 3 said the French medical device company suspended implants of the Aeson artificial hearts following a quality issue affecting some of its prostheses.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Nebraska is sixth U.S. state with Omicron coronavirus variant
/in Coronavirus Cases, Coronavirus Disease (COVID-19) Pandemic, Nebraska, New York, Omicron (B.1.1.529) (South Africa), United StatesA sixth U.S. state – Nebraska – reported the Omicron variant of the coronavirus after detecting six confirmed cases of the highly contagious strain, the state’s health department said on December 3.
Study: Adenovirus Could be Cause of Rare Blood Clots in AstraZeneca Vaccine
/in AstraZeneca, Blood Clots, Coronavirus Vaccines, COVID-19 Studies, R&DScientists believe they have found the likely cause of blood clotting in some recipients of the Oxford-AstraZeneca Covid-19 vaccine.
Former Immunomedics CFO Charged with Insider Trading
/in Business, Charges, Insider TradingThe U.S. Securities and Exchange Commission filed insider trading charges against Usama Malik, the former chief financial officer of Immunomedics Inc.
Research Roundup: A Potential Cause of Alzheimer’s Disease and More
/in Alzheimer’s disease, Business, Clinical Trials, Diabetes, Fat Cells, Lyme Disease, R&D, Researchers, StudiesBioSpace reviewed some of the more interesting scientific studies recently published, including research into a potential cause of Alzheimer’s disease and how deleting dysfunctional fat cells could alleviate diabetes.
BioNTech CEO says vaccine upgrade on the cards, ready to move quickly
/in BioNTech, BNT162b2 (Pfizer and BioNTech), Business, COVID-19 Vaccines, Omicron (B.1.1.529) (South Africa), R&DBioNTech should be able to adapt the German company’s coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, CEO Ugur Sahin told the Reuters Next conference on December 3.
WHO’s top scientist says Omicron could displace Delta
/in Delta Variant (B.1.617.2; India), Omicron (B.1.1.529) (South Africa), R&D, Scientists, World Health OrganizationThe World Health Organization’s chief scientist told the Reuters Next conference on December 3 the Omicron variant could become dominant because it is highly transmissible, but that a different vaccine may not be needed.
Omicron COVID-19 variant found in five U.S. states
/in Coronavirus Disease (COVID-19) Pandemic, New York, Omicron (B.1.1.529) (South Africa), United StatesNew York confirmed five cases of the Omicron coronavirus variant – the NY governor said on December 2 – bringing to five the number of U.S. states having detected the variant, with 10 reported infections nationwide.
BioNTech CEO says likelihood of annual COVID-19 vaccines increasing
/in BNT162b2 (Pfizer and BioNTech), Business, Coronavirus Disease 2019 (COVID-19), Coronavirus Vaccines, COVID-19 Vaccines, Omicron (B.1.1.529) (South Africa), United StatesThe likelihood that people will need to have an annual Covid-19 vaccine – similar to the influenza shot – is increasing, BioNTech chief executive and co-founder Ugur Sahin told the Reuters Next conference on December 3.
Novartis Inks Potential $1.5 Billion Parkinson’s Deal with UCB
/in Business, Clinical Trials, Deals, Novartis, Parkinson’s disease, R&DSwiss drug giant Novartis and Belgian pharma company UCB announced a deal to co-develop and commercialize two products targeting Parkinson’s disease, UCB0599 and UCB7853.